1. Background
=============

Cataract is the turbidity in the lens of the eyes that may impair contrast sensitivity, glare sensitivity, and perception of light ([@A61041REF1]). Surgery is the only treatment that can affect visual impairment due to cataract ([@A61041REF2]). The vast majority of patients undergoing cataract surgery are older people with high CAD or IHD risk factors, such as atherosclerosis, high blood pressure, and diabetes mellitus ([@A61041REF3]). They face more ischemic events, hemodynamic instability, and changes in heart rate and plasma glucose during general anesthesia. Local anesthesia seems to have many advantages over general anesthesia and cause better analgesia after surgery ([@A61041REF4]). Among the local anesthesia techniques, retrobulbar, and topical block are more preferred among anesthesiologists and eye surgeons due to the fact that they are safer, more affordable, and less expensive ([@A61041REF5]).

The retrobulbar block is a painful process and use of analgesic and sedative medications may be helpful. These premeditations are administered to keep the patients painless, calm, and immobile ([@A61041REF6]). Opioids, benzodiazepines, propofol, fentanyl, and dexmedetomidine were frequently used alone or in combination during cataract surgery. Since all of these drugs have unwanted side effects ([@A61041REF7]), the evaluation of new drugs that are potentially clinically relevant in this regard is necessary.

Melatonin or N-acetyl methoxytryptamine is a neurohormone produced by the pineal gland and the retina ([@A61041REF8]). The major physiological role of melatonin is the regulation of sleep and awakening rhythm ([@A61041REF9]). Several studies revealed that the use of melatonin as premedication reduced perioperative anxiety without cognitive impairment such as memory impairment ([@A61041REF10]). In addition, analgesic, antioxidant, and inflammatory effects of melatonin have been reported. Therefore, with these characteristics as well as being harmless, melatonin is considered as a potential drug to reduce pain and anxiety during cataract surgery ([@A61041REF9]).

Acetaminophen is a widely-used drug to relieve mild to moderate pain. After years of its use, its efficacy and harmlessness have been proven and is described as a standard analgesic drug ([@A61041REF11]).

2. Objectives
=============

The purpose of this study was to compare the administration of melatonin and acetaminophen on pain and hemodynamic changes in retrobulbar block, which was performed in patients undergoing cataract surgery.

3. Methods
==========

This double-blind, randomized, clinical trial was approved by the University Ethics Committee (Code of Ethics 1930474206) and registered at the Iranian Registry of Clinical Trials (IRCT2015012315963N4). The study was conducted from Mar 2014 to Nov 2014 in Amir Al-Momenin Hospital of Rasht, Iran. The protocols of this study were performed in accordance with ethical guidelines of the 1975 Helsinki Declaration. After obtaining the informed consent, a total of 180 patients of both genders scheduled for cataract surgery (aged 50 to 90) with The American Society of Anesthesiologists (ASA) I-III were included. The exclusion criteria included: coagulation disorders, using anticoagulant drugs, cognitive impairment, Alzheimer\'s disease, history of allergy to local anesthetic drugs, claustrophobia, spontaneous chronic cough, addiction, and chronic analgesics. In addition, individuals were excluded from the analysis if they had extended surgical time, block failure, and trigeminocardiac reflex. Patients were randomized by random allocation method divided into three groups, each containing 60 patients. Group M received 6 mg melatonin tablets (made by nature-made United States), group A received acetaminophen 500 mg (manufactured by the Arya Pharmaceuticals Co, Iran) and the control group (C) received placebo. All drugs were given orally with 10 mL of water 60 minutes before entering the operating room. The medications were taken by the nurse blinded to the type of drug used. In the operating room and under standard monitoring, all patients were given fentanyl 0.5 μg/kg and midazolam 0.03 mg/kg intravenously ([@A61041REF12]).

3.1. Retrobulbar Block
----------------------

A 3 cm length 23-gauge retrobulbar needle inserted through the lower eyelid at the junction between lateral and inferior orbital edge. The needle is advanced posteriorly until it was felt to be within the muscle cone. At this point; 2 to 3 mL of anesthetic mixture solution (lidocaine 2% and hyaluronidase) was slowly injected. Cardiac and respiratory systems were monitored and supplemental oxygen was given via nasal cannula at 5 L/min.

Hemodynamic changes including heart rate (HR), oxygen saturation (O~2~ Sat), systolic blood pressure (SBP), and diastolic blood pressure (DBP) were noted and the mean arterial pressure (MAP) was calculated. Score of pain at the entrance to the operating room (T1), during retrobulbar block (1 minute after block) (T2), during surgery (5 minutes after the start of operation) (T3), 20 minutes after the start of operation (T4), at the end of surgery (T5), and in the recovery room (T6) were also recorded. The pain score was evaluated by a numerical rating scale (NRS), in which the patient selects a number from zero to 10, which is a reflection of the severity of the pain. In addition, pain was classified as no pain (0), mild (1 - 2), moderate (3 - 4), severe (5 - 6), very severe (7 - 8), and extremely severe (9 - 10). Before surgery, all patients were instructed to describe pain on NRS. Complications during the block, surgery, and recovery including nausea, vomiting, and reduction of oxygen saturation were reported. The nausea, vomiting, and reduction of oxygen saturation were treated by administration of ondansetron (0.08 mg/kg IV) and oxygen via face mask, respectively.

Additional fentanyl would be administered if pain score was more than three during the surgery.

3.2. Statistical Analysis
-------------------------

Kolmogorov-Smirnov test was used to evaluate the normality of the data. One way ANOVA or Kruskal-Wallis test was used to compare the pain score and hemodynamic changes. Tukey\'s post Hoc test was used to compare the two groups. To compare qualitative variables, the χ^2^ and Fisher\'s exact test were used. P \< 0.05 was considered as significant difference.

4. Results
==========

Out of 180 patients, 5 were excluded due to the fact that the surgery lasted for more than one hour or failing block ([Figure 1](#A61041FIG1){ref-type="fig"}). Demographic features including sex and ASA were not statistically different among all three groups ([Table 1](#A61041TBL1){ref-type="table"}). In the case of age, Turkey\'s post Hoc analysis demonstrated no significant differences among each two groups. MAP, HR, and O~2~ Sat did not show significant differences before surgery, during retrobulbar block, as well as during and after surgery in the control group with melatonin and acetaminophen groups ([Figure 2](#A61041FIG2){ref-type="fig"}).

![CONSORT flow diagram of this study](aapm-08-05-61041-i001){#A61041FIG1}

![Changes in mean arterial pressure (MAP) (A), heart rate (HR) (B), and oxygen saturation (O~2~ Sat) (C) during assessment. All data are expressed as mean ± SEM (abbreviations: A, acetaminophen; C, control; M, melatonin; T1, entering to the operating room; T2, during retrobulbar block; T3, during operation; T4, 20 minutes after operation; T5, end of operation; T6, recovery room).](aapm-08-05-61041-i002){#A61041FIG2}

###### Demographic Features Including Age, Sex and ASA

  Variable             Group C      Group M        Group A      P Value
  -------------------- ------------ -------------- ------------ ---------
  **N**                58           59             58           
  **Age, y**           68.3 ± 1.6   63.59 ± 1.38   67.9 ± 1.3   0.035
  **Female/Male**      29/29        33/26          31/27        0.222
  **ASA (I/II/III)**   3/37/18      10/35/14       4/36/18      0.812

Abbreviations: A, acetaminophen; C, control; M, melatonin.

Distribution of pain severity in different stages of surgery was shown in [Table 2](#A61041TBL2){ref-type="table"}. All patients were evaluated for pain before entering the operating room; their pain score was zero. None of the patients experienced very severe or extremely severe pain. We found that in the T2 stage, the number of patients in the no pain class significantly increased in either melatonin or acetaminophen groups compared to the control group (P \< 0.05). In the rest of the stages, the distribution of painless subjects in the studied groups did not show any significant difference. Compared to control group, melatonin and acetaminophen groups were able to significantly reduce pain score during retrobulbar block (P \< 0.01 and P \< 0.05, respectively) ([Figure 3](#A61041FIG3){ref-type="fig"}). In respect to classification of pain score, no significant difference was found during surgery, at the end of surgery, and in the recovery stages in all groups. The amount of additional fentanyl in the control group was 5.6 ± 1.74 μg/dL and in acetaminophen and melatonin groups were 1.72 ± 0.84 μg/dL and 1.27 ± 0.72 μg/dL, respectively. The amount of fentanyl in the melatonin group, however, not acetaminophen group, decreased compared with the control group, significantly (P \< 0.05). Only one patient showed complications in the melatonin group.

###### Distribution of Patients Based on the Severity of Pain in the Different Stages of Operation

  Variable                     Number of Patients                                            
  ---------------------------- ---------------------------------------------- ---- ---- ---- ----
  **Control (n = 58)**                                                                       
  No pain (0)                  44                                             42   37   40   40
  Mild pain (1 - 2)            11                                             10   17   15   15
  Moderate pain (3 - 4)        3                                              0    0    0    0
  Severe pain (5 - 6)          0                                              0    4    3    3
  **Acetaminophen (n = 58)**                                                                 
  No pain (0)                  53^[a](#A61041TBL2FN2){ref-type="table-fn"}^   41   38   36   34
  Mild pain (1 - 2)            5                                              10   14   20   20
  Moderate pain (3 - 4)        0                                              6    2    1    2
  Severe pain (5 - 6)          0                                              1    4    1    2
  **Melatonin (n = 59)**                                                                     
  No pain (0)                  55^[b](#A61041TBL2FN3){ref-type="table-fn"}^   50   46   45   44
  Mild pain (1 - 2)            4                                              7    12   14   14
  Moderate pain (3 - 4)        0                                              2    1    0    0
  Severe pain (5 - 6)          0                                              0    0    0    1

Abbreviations: A, acetaminophen; C, control; M, melatonin.

^a^P \< 0.05 compared to the control group.

^b^P \< 0.01 compared to the control group.
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5. Discussion
=============

Our findings showed that administration of acetaminophen and melatonin reduced the pain in the retrobulbar block, however, not during and after surgery. In addition, melatonin was able to reduce the need for additional analgesic therapy during the operation.

In the present study, melatonin was able to reduce the pain score during retrobulbar block. Although pain score decreased during and after operation, the differences were not significant. The effect of melatonin on pain was reported in several studies ([@A61041REF13]-[@A61041REF19]). In the only study on retrobulbar block, melatonin had no effect on pain during the block and during and after surgery ([@A61041REF18]). A systematic study has shown that the effects of melatonin in the various stages of the surgical process are limited and there are contradictory results. This contradiction may be due to the dosage, sex, anxiety levels, and also high risks of bias based on the small sample size used in various studies. Nevertheless, the evidence available from clinical trials suggests that melatonin, as an anxiolytic and analgesic agent, can be an alternative candidate for drugs prescribed before surgery ([@A61041REF13]). Reducing the amount of pain during retrobulbar block by melatonin in this study is contrary to the findings of Khezri et al. ([@A61041REF18]). This contradiction may be associated with the quality of melatonin, and how and when it was taken. They used sublingual route 90 min before entering the operation room whereas oral melatonin was applied in our study 60 min before operation. Both sublingual and oral melatonin showed a positive analgesic effect in human experimental studies. Time to maximal plasma concentration value and elimination half-life for sublingual and oral melatonin were approximately 50 min and 45 min, respectively ([@A61041REF19]). Therefore, it seems that administration of melatonin, 90 min before operation, may reduce its analgesic effect.

Applying additional fentanyl during surgery was reduced by melatonin. This decrease occurred despite no significant reduction of pain score during or after operation in the melatonin group compared to the control group. The reason was that we compared pain score in each stage of operation, however, fentanyl consumption was compared in overall stages. In addition, applying more fentanyl itself led to a reduction of pain score in the control group. In a review article, three out of five studies reported a reduction in requirement of additional fentanyl during operation when the effect of melatonin with placebo was compared ([@A61041REF20]). In the only study conducted in retrobulbar block, no significant difference in the use of fentanyl in the melatonin and control groups was found ([@A61041REF18]).

In our study, melatonin had no effect on pain relief during and after operation. Our findings are consistent with the results of the study by Khezri et al ([@A61041REF18]). In addition, melatonin was not able to change the hemodynamic parameters during retrobulbar block and in all operative and postoperative stages. Three studies reported the effect of melatonin on arterial pressure and heart rate and showed no significant changes in different stages of operation ([@A61041REF14], [@A61041REF16], [@A61041REF18]). In all the mentioned studies, the percentage of oxygen saturation has not been evaluated.

To evaluate the effect of acetaminophen on pain, a single dose of 500 mg of acetaminophen was administered one hour before surgery. The time of administration was determined based on three parameters: Previous studies, giving the medications at the same time, and the peak concentration of acetaminophen after oral administration (approximately 45 to 60 minutes) ([@A61041REF21]).

Acetaminophen, like melatonin, could reduce the pain score during retrobulbar block, however, not during operation time and postoperative stages. The use of additional fentanyl was not different between acetaminophen and control groups.

Many investigations have reported the effect of postoperative administration of non-opioid medications ([@A61041REF22]-[@A61041REF25]), including acetaminophen ([@A61041REF26]-[@A61041REF30]), on the postoperative pain, and opioid sparing. However, the efficacy of preoperative administration of acetaminophen on pain after surgery was reported only by limited studies ([@A61041REF31]). As long as we have studied, the effect of acetaminophen on pain in the retrobulbar block has not been studied yet and the present study, for the first time, shows the analgesic effects of acetaminophen in the retrobulbar block.

The evaluation of hemodynamic parameters in the acetaminophen group did not delineated any significant difference at all stages of surgery. Limited studies have been conducted on the effect of single-dose acetaminophen on hemodynamic parameters in patients ([@A61041REF32], [@A61041REF33]). Furthermore, none of them are related to retrobulbar block and cataract surgery. It seems that oral administration of acetaminophen does not alter the hemodynamic parameters.

One of the limitations of this study is the difference in pain tolerance in different individuals, which makes it difficult to judge the patient\'s real pain. We applied NRS-Visual Analogue Scale (VAS) and NRS are two pain assessment tools that are least problematic in most studies ([@A61041REF34]). Individual differences between surgeons and anesthetists can also cause bias. In this study, all surgeries were performed by the same anesthetist and the same surgeon.

For the first time, in this study, the analgesic effects of acetaminophen were shown in retrobulbar block. Melatonin, in addition to reducing pain during the retrobulbar block, reduced the amount of fentanyl consumption. Considering the doses used in this study and their safety in higher doses, it seems that administration of melatonin and acetaminophen would have a beneficial effect to control the pain in the retrobulbar block.
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